association

Full identifier: http://purl.org/np/RAam_9vjU3Ci-Ay6LC2dukZTEN8XfRex_qIykO7G1Cn7w#association

Assigned to 1 class:

Minted in Nanopublication

 RAam_9vjU3 comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAam_9vjU3... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-07-03T13:11:16.701+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAam_9vjU3... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAam_9vjU3... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAam_9vjU3... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T11:11:16.701Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
zavesca is a glucosylceramide synthase inhibitor indicated as monotherapy for treatment of adult patients with mild moderate type 1 gaucher disease for whom enzyme replacement therapy is not a therapeutic option 1 1 zavesca is a glucosylceramide synthase inhibitor indicated as monotherapy for the treatment of adult patients with mild to moderate type 1 gaucher disease for whom enzyme replacement therapy is not a therapeutic option e g due to allergy hypersensitivity or poor venous access
Leoni Bücken
2021-07-03T11:11:16.701Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T11:11:16.701Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T11:11:16.701Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T11:11:16.701Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T11:11:16.701Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T11:11:16.701Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T11:11:16.701Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)